Bristol Myers Squibb

Promotional graphic for a talk on new therapeutic modalities in drug discovery featuring Julie Carlisle, Partner and European Patent Attorney at Mewburn Ellis, with her photo.
Pharmaceuticals

Beyond the “Undruggable”: How new therapeutic modalities are reshaping drug discovery

For decades, small-molecule drug discovery was built around a straightforward principle: identify a protein's active site, design a compound that binds to it, and inhibit…
September 2, 2026
3D rendering of blue antibody proteins with complex surface structures on a black background.
AI

Harbour BioMed’s AI-driven antibody discovery and next-generation therapies

Harbour BioMed's first AI-enabled drug candidate, LET003, recently demonstrated promising preclinical results, marking a milestone in the company's integration of generative AI with antibody engineering.…
August 3, 2026

Sign up to get access​

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Please provide accurate and verifiable contact information to ensure proper use of our materials and prevent misuse. Thank you for your understanding!
Name*
Important: To prevent misuse of our materials, all report download requests undergo a verification and approval process. Providing your email does not guarantee immediate access.
Consent
This field is hidden when viewing the form
This field is hidden when viewing the form

Sign up to get access

Please provide accurate and verifiable contact information to ensure proper use of our materials and prevent misuse. Thank you for your understanding!

Important: To prevent misuse of our materials, all report download requests undergo a verification and approval process. Providing your email does not guarantee immediate access.

Subscribe to our newsletter